THOMAS SCHMADEKE: Open Payments
NPI 1760455083 · RED OAK, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 41 payments from 19 companies in 2025. Trend: 2023 $723 · 2024 $711 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Axsome Therapeutics, Inc. | 3 | $88 |
| PFIZER INC. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Lilly USA, LLC | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Novo Nordisk Inc | 3 | $55 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $38 |
| ABBVIE INC. | 2 | $32 |
Products named: LEQVIO, Auvelity, CAPLYTA, ELIQUIS, PREVNAR 20, MOUNJARO, Ozempic, REXULTI.
Industry payments across IA — which companies pay providers there.
